{
    "id": "correct_subsidiary_00091_2",
    "rank": 20,
    "data": {
        "url": "https://mergr.com/kyphon-acquires-st.-francis-medical-technologies",
        "read_more_link": "",
        "language": "en",
        "title": "Kyphon Acquires St. Francis Medical Technologies",
        "top_image": "",
        "meta_img": "",
        "images": [
            "https://mergr.com/home/img/logo-mergr-white.svg",
            "https://mergr-image-uploads.s3.amazonaws.com/professionals/MartySutter.jpg",
            "https://mergr-image-uploads.s3.amazonaws.com/professionals/PetriVainio.jpg",
            "https://mergr-image-uploads.s3.amazonaws.com/professionals/1715313607630293.jpg",
            "https://mergr-image-uploads.s3.amazonaws.com/professionals/EvisHursever.jpg",
            "https://mergr-image-uploads.s3.amazonaws.com/professionals/ScottBarry.jpg",
            "https://mergr.com/home/img/logo-mergr.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "On December 4, 2006, Kyphon acquired medical products company St. Francis Medical Technologies from EW Healthcare Partners for 525M USD",
        "meta_lang": "",
        "meta_favicon": "https://mergr.com/assets/member/img/favicon.ico",
        "meta_site_name": "",
        "canonical_link": null,
        "text": "Kyphon, located in Sunnyvale, California, develops, manufactures and markets minimally invasive medical devices, which employ a proprietary balloon technology, to help surgeons repair spine fractures caused by osteoporosis, cancer and trauma. Approximately 700,000 of these fractures, also known as vertebral compression fractures ('VCF'), are diagnosed each year in the U.S. Left untreated, they can result in significant pain, deformity and reduced respiratory function, as well as shortened life expectancy\n\nDEAL STATS # Overall 1 of 1 Sector (Medical Products) 1 of 1 Type (Add-on Acquisition) 1 of 1 State (California) 1 of 1 Country (United States) 1 of 1 Year (2006) 1 of 1 Size (of disclosed) 1 of 1\n\nEssex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.\n\nDEAL STATS # Overall 9 of 52 Sector (Medical Products) 3 of 23 Type (Add-on Acquisition) 4 of 34 State (California) 3 of 16 Country (United States) 8 of 45 Year (2006) 4 of 4 Size (of disclosed) 4 of 22\n\nPREVIOUS DEAL\n\nDATE TARGET DEAL TYPE VALUE\n\nFOLLOWING DEAL\n\nDATE TARGET DEAL TYPE VALUE"
    }
}